Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY: BSX )

101.14 +2.22 (+2.24%)
Official Closing Price Updated: 4:10 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Investors Liked These 2 Stock Buyouts Tuesday
Market performance was mixed as investors prepared for more insight on interest rates. 
Via The Motley Fool
Apollo Endosurgery (NASDAQ: APEN) Enters Into Agreement to be Acquired by Boston Scientific (NYSE: BSX) for $615 Million
Apollo Endosurgery, Inc. (NASDAQ: APEN) is a medical technology company, which is focused on the research and development of advanced, 
Via Spotlight Growth
Exposures Product Safety
Apollo Endosurgery (APEN) Stock Soars 65% on Boston Scientific Deal
Apollo Endosurgery is about to be acquired by Boston Scientific. Here's what this new deal means for BSX and for APEN stock. 
Via InvestorPlace
Golden Cross Appears Before Boston Scientific Investors
Via Benzinga
Scotts Miracle-Gro, Walgreens Boots Alliance And 2 Other Stocks Insiders Are Selling
US crude oil futures traded higher this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Boston Scientific Posts Mixed Q3 Earnings, Cuts Annual Guidance
Via Benzinga
Boston Scientific Rises Despite Mixed Earnings, Light 2022 Guidance
Boston Scientific's third quarter came out mixed and profit guidance for 2022 missed. 
Via Investor's Business Daily
Where Boston Scientific Stands With Analysts
Analysts have provided the following ratings for Boston Scientific (NYSE:BSX) within the last quarter: 
Via Benzinga
S&P 500 Component DexCom Set For Further Price, Earnings Growth
Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023. 
Via MarketBeat
Topics Stocks
Exposures US Equities
Edwards Life Sciences Stock Disaster Could Be Your Bounty
Heart disease equipment maker Edwards Life Sciences (NYSE: EW) stock has fallen (-46%) on the year after a disastrous reaction to its Q3 2022 earnings report. 
Via MarketBeat
Topics Death
Exposures COVID-19 Death
Intuitive Surgical Stock is Both a Legacy and Next-Gen Play
It’s hard to believe that the da Vinci Surgical System developed by Intuitive Surgical (NASDAQ: ISRG) is turning 22 years old since its U.S. Food and Drug 
Via MarketBeat
Topics Economy
Exposures COVID-19 Interest Rates Supply Chain
Boston Scientific Adds 'Novel' Technology Via This Acquisition For Interventional Oncology
Via Benzinga
Boston Scientific Shares Are Flying Higher On Q2 Wall Street Beat, Upbeat Guidance
Via Benzinga
This Congresswoman Is Selling Energy Stocks, But Purchased These 2 Dividend Paying Retailers
Congresswoman Lois Frankel (D-FL) made more than 430 trades in the past three years, which are typically filed in the range of $1,000 to $15,000 in shares, according to Capitol Trades. 
Via Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $3,000 Today
Boston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 1.59% on an annualized basis producing an average annual return of 8.01%. Currently, Boston Scientific has a market... 
Via Benzinga
Big Tech Misses
Good Morning Everyone! Remember, the bigger the drawdown the better bigger the bounce. 
Via Benzinga
Boston Scientific: Q3 Earnings Insights
Boston Scientific (NYSE:BSX) reported its Q3 earnings results on Wednesday, October 26, 2022 at 06:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
What 7 Analyst Ratings Have To Say About Boston Scientific
Analysts have provided the following ratings for Boston Scientific (NYSE:BSX) within the last quarter: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022
Upgrades 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
Upgrades 
Via Benzinga
Penumbra Stock Hits 80-Plus Relative Strength Rating Benchmark
Penumbra stock cleared a key 80-plus relative strength benchmark Monday, with a jump to 87 from 79 on Friday. 
Via Investor's Business Daily
Wearable Health Technology Market To Experience Significant Growth Report Says (RKLY), (MDT), (BSX), (WHSI)
Via AB Newswire
Why Jim Cramer Says He Likes This Stock Over Medtronic
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Boston Scientific Corporation (NYSE: BSX) is a much better company than Medtronic plc (NYSE: MDT). 
Via Benzinga
10 Best Fidelity Funds to Buy Now
Given the unique challenges of the new normal, investors navigating these waters should consider the best Fidelity funds to buy now. 
Via InvestorPlace
Coinbase Global, T-Mobile US And 2 Other Stocks Insiders Are Selling
U.S. crude oil futures traded lower this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
  This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
The 7 Best Fidelity Funds for Retirees
These are the best Fidelity funds for retirees. FCNTX, FDIG, FXAIX, FSPHX, FSUTX, FSMO and FDVLX can make great buys in August. 
Via InvestorPlace
$100 Invested In This Stock 10 Years Ago Would Be Worth $800 Today
Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 11.57% on an annualized basis producing an average annual return of 22.95%. Currently, Boston Scientific has a market... 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.